<DOC>
	<DOCNO>NCT02483793</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety tamsulosin reduce stent discomfort pediatric population peri-operative period . The secondary objective compare efficacy tamsulosin oxybutynin reduce stent discomfort .</brief_summary>
	<brief_title>Prospective Trial Comparing Oxybutynin Tamsulosin Stent Pain Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Patients age 418 year enrol study . We include patient ureteral stent placement procedure . Patients developmental delay unable verbalize pain level exclude .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>